Who Should Be Treated
NIH Recommendations for Hepatitis B
NIH Consensus Statement 2008
Experts from across the U.S. tackled the complex issues in the management of chronic hepatitis B (HBV) at the National Institutes of Health’s (NIH) first Consensus Conference on Hepatitis B, held Oct. 20-22, 2008 in Bethesda, MD.
To examine the key questions, an independent 12 member panel of experts was assembled to weigh the available evidence and make general recommendations for managing HBV. Two dozen clinical and scientific experts in the field of HBV provided testimony about the burden of disease, natural history of disease, and the benefits and risks of the approved therapies.
Read the complete 2008 NIH Consensus Statement.
NIH Conference 2006
In 2000, almost ten years after the first drug was approved for chronic hepatitis B, the National Institute of Diabetes and Digestive and Kidney Diseases of the National Institutes of Health (NIH) sponsored the first NIH conference on "The Management of Hepatitis B: 2000", in Bethesda, MD.
The NIH recommendations attempted to standardize (and reform) terminologies describing hepatitis B infected individuals and identify general criteria regarding monitoring and treatment.
For more information, read our summary of NIH Recommendations 2000.